Prozac and a drug used to treat THRUSH ‘potently impaired’ Covid in lab tests, study finds
A common antidepressant and an antifungal treatment used for decades could help treat Covid, a new study claims.
The antifungal drug itraconazole, which is used to treat thrush and infected toenails, killed the virus in experiments.
Fluoxetine, the antidepressant better known as Prozac, was also effective, data shows.
Both the drugs are already approved for human use and worked best when combined with the antiviral remdesivir, scientists said.
It offers hope of a ‘Covid cocktail’, say the German and Finnish team, who now hope to start human trials.
The antifungal drug itraconazole, which is used to treat thrush and infected toenails, killed the virus in experiments. Fluoxetine, the antidepressant better known as Prozac (pictured), was also effective, data shows
Both treatments blocked SARS-CoV-2 – the virus that causes Covid-19 – from growing and replicating in cells grown in a lab, the research found.
There is no cure for Covid but some treatments have been found which do increase the likelihood of survival.
For example, the Oxford-led RECOVERY trial found the steroid dexamethasone and the arthritis drugs tocilizumab and sarilumab are effective at helping treat Covid-19.
Dexamethasone is a £5 drug which reduces risk of dying by up to 35 per cent on its own.
A common antidepressant and an antifungal treatment used for decades could help treat Covid, a new study claims
One tablet of ASPIRIN a day can reduce your risk of catching Covid-19 by up to 29 per cent
Taking aspirin pills may help protect against coronavirus infection, a study suggests.
The common, cheap and safe drug is often prescribed to prevent heart disease and stroke as well as a regular over-the-counter painkiller.
Data from more than 10,000 people who were tested for Covid between February and June 2020 revealed one aspirin tablet (75mg) a day led to a 29 per cent lower risk of catching the virus.
It remains unknown exactly how aspirin may prevent coronavirus infection but the authors believe its antiviral properties come from an ability to change how the immune system responds to the pathogen.
People who only receive dexamethasone however still had a death rate of 35.8 per cent but this dropped to just 25.3 per cent when they were also given a single dose of either tocilizumab or sarilumab which costs around £1,000 per treatment.